3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
8
Oropharyngeal Neoplasms
6
Lung Neoplasms
5
Mesothelioma, Malignant
4
Laryngeal Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Mouth Neoplasms
3
Hypopharyngeal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Paranasal Sinus Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Medulloblastoma
2
Lymphoid Interstitial Pneumonia
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma
2
Breast Neoplasms
2
Vaginal Neoplasms
1
Urethral Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sinonasal undifferentiated carcinoma
1
SCLC
1
Interventions
sintilimab
1
dacomitinib
1
Platinum
1
Pemetrexed
1
Immune Checkpoint Inhibitors
1
Data Collection
1
Carboplatin
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Non-small Cell Lung Cancer Metastatic
×
Platinum
×
Clear all
NCT05407155
2026-04-23
BETTER
Fudan University
Phase NA
Active not recruiting
56 enrolled